Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $841.6500 (-0.83%) ($841.4400 - $841.6500) on Wed. Dec. 20, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.14% (three month average) | RSI | 59 | Latest Price | $841.6500(-0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.8% a day on average for past five trading days. | Weekly Trend | REGN advances 1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IVE(69%) XLF(65%) EWG(56%) SDY(74%) XLV(66%) | Factors Impacting REGN price | REGN will decline at least -0.57% in a week (0% probabilities). VIXM(-61%) UNG(-31%) BNDX(-14%) VXX(-92%) TBT(-13%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.57% (StdDev 1.14%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $854.59(-1.51%) | 10 Day Moving Average | $854.94(-1.55%) | 20 Day Moving Average | $834.93(0.8%) | To recent high | -4% | To recent low | 8.6% | Market Cap | $89.239b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |